The present invention relates generally to medical devices and methods. More specifically, the present invention relates to ultrasound catheter devices and methods for treating occlusive intravascular lesions.
Catheters employing various types of ultrasound transmitting members have been successfully used to ablate or otherwise disrupt obstructions in blood vessels. Specifically, ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries has been particularly successful. Various ultrasonic catheter devices have been developed for use in ablating or otherwise removing obstructive material from blood vessels. For example, U.S. Pat. Nos. 5,267,954 and 5,380,274, issued to an inventor of the present invention and hereby incorporated by reference, describe ultrasound catheter devices for removing occlusions. Other examples of ultrasonic ablation devices for removing obstructions from blood vessels include those described in U.S. Pat. No. 3,433,226 (Boyd), U.S. Pat. No. 3,823,717 (Pohlman, et al.), U.S. Pat. No. 4,808,153 (Parisi), U.S. Pat. No. 4,936,281 (Stasz), U.S. Pat. No. 3,565,062 (Kuris), U.S. Pat. No. 4,924,863 (Sterzer), U.S. Pat. No. 4,870,953 (Don Michael, et al), and U.S. Pat. No. 4,920,954 (Alliger, et al.), as well as other patent publications WO87-05739 (Cooper), WO89-06515 (Bernstein, et al.), WO90-0130 (Sonic Needle Corp.), EP, EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2438648 (Pohlman). While many ultrasound catheters have been developed, however, improvements are still being pursued.
Typically, an ultrasonic catheter system for ablating occlusive material includes three basic components: an ultrasound generator, an ultrasound transducer, and an ultrasound catheter. The generator converts line power into a high frequency current that is delivered to the transducer. The transducer contains piezoelectric crystals which, when excited by the high frequency current, expand and contract at high frequency. These small, high-frequency expansions and contractions have both longitudinal and transverse components (relative to an axis of the transducer and the catheter), which are amplified by the transducer horn into vibrational energy. The vibrations are then transmitted from the transducer through the ultrasound catheter via an ultrasound transmission member (or wire) running longitudinally through the catheter. The transmission member transmits the vibrational energy to the distal end of the catheter where the energy is used to ablate or otherwise disrupt a vascular obstruction.
To effectively reach various sites for treatment of intravascular occlusions, ultrasound catheters of the type described above typically have lengths of about 150 cm or longer. To permit the advancement of such ultrasound catheters through small and/or tortuous blood vessels such as the aortic arch, coronary vessels, and peripheral vasculature of the lower extremities, the catheters (and their respective ultrasound transmission wires) must typically be sufficiently small and flexible. Due to attenuation of ultrasound energy along the long, thin, ultrasound transmission wire, a sufficient amount of vibrational energy must be applied at the proximal end of the wire to provide a desired amount of energy at the distal end.
An ultrasound transmission wire is usually coupled at its proximal end with the transducer by means of a sonic connector. The sonic connector typically has a significantly larger diameter than that of the ultrasound transmission member, the difference in diameters helping to amplify the vibrational energy being transmitted from the transducer to the transmission wire. Several different means have typically been used for connecting the ultrasound transmission wire with the transducer via the sonic connector, such as complementary threads, pressure fitting and the like. One shortcoming of currently available devices is that they may allow the transmission wire to rotate independently from the catheter body. In these devices, it is not possible to rotate the ultrasound transmission wire by rotating, for example, a proximal handle or sonic connector assembly, since the transmission wire rotates freely and independently of the catheter body and such a proximal assembly.
Another potential drawback of currently available devices is that they often to not include optimal means for removing particles that are broken up or dislodged by the catheter. Yet another possible shortcoming is that many ultrasound catheter devices include a distal tip, as mentioned above, but do not have means for preventing the distal tip from migrating from the device into the patient's body if the tip breaks. Similarly, most ultrasound transmission members include multiple components for transmitting vibrational energy, which causes stresses at the connection points of the multiple components during use and potential breakage of the ultrasound transmission wire or other components. Also, ultrasound transmission wires are often exposed to increased amounts of stress due to one or more bends in patient vasculature, causing increased wear and tear on the transmission wire.
Therefore, a need exists for improved ultrasound catheter devices and methods that provide ablation or disruption of vascular occlusions. Ideally, such ultrasound catheters would include means for reducing or eliminating rotational motion of the ultrasound transmission wire relative to the catheter body. It would also be advantageous to have ultrasound catheters which included means for removing particles, preventing distal tip and ultrasound transmission wire migration, preventing stress at component connection points and/or preventing stress at bends in the catheter. Such catheter devices would ideally be sufficiently thin and flexible to be advanced through narrow, tortuous vasculature, such as the coronary vasculature, while also being configured to enhance the usable life of the ultrasound transmission wire. At least some of these objectives will be met by the present invention.
Ultrasound catheter devices and methods provide enhanced disruption of blood vessel obstructions. Generally, ultrasound catheters include an elongate flexible catheter body with one or more lumens, an ultrasound transmission member extending longitudinally through the catheter body lumen and a distal head coupled with the transmission member and positioned adjacent the distal end of the catheter body for disrupting occlusions. Improved features of ultrasound catheters include prevention of independent rotation of the ultrasound transmission member, a safety anchor for the distal head, a one-piece transmission member/distal head and the like.
In one aspect of the invention, an ultrasound catheter for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; a sonic connector coupled with the proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with an ultrasound transducer device; and a connector housing coupled with the proximal end of the catheter body for housing the sonic connector and a proximal portion of the ultrasound transmission wire and for preventing the ultrasound transmission member from rotating relative to the catheter body.
In some embodiments, the connector housing comprises a sonic connector cavity for holding the sonic connector to prevent it from rotating relative to the connector housing. Also in some embodiments, the ultrasound transducer device includes an ultrasound transducer housing having a proximal end and a distal end. In such embodiments, the connector housing may optionally be coupled with the distal end of the ultrasound transducer housing via coupling means allowing for manual coupling without using coupling tools. In one embodiment, the connector housing is coupled with the distal end of the ultrasound transducer housing via complementary threads on the two housings. Alternatively, the connector housing may be coupled with the distal end of the ultrasound transducer housing via pressure fitting. In some of these embodiments, the ultrasound transducer housing further comprises at least one protrusion on its distal end and a slidable collar for fitting over the at least one protrusion to press a portion of the distal end of the ultrasound transducer housing against the connector housing, thereby further securing the ultrasound transducer housing to the connector housing.
In another aspect, an ultrasound catheter for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; a sonic connector coupled with the proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with an ultrasound transducer device; and a rotation control member coupled with the proximal end of the catheter body for preventing the ultrasound transmission member from rotating relative to the catheter body. Optionally, the rotation control member may comprise a connector housing for housing the sonic connector and a proximal portion of the ultrasound transmission member. In some of such embodiments, the connector housing may comprise a sonic connector cavity for holding the sonic connector to prevent it from rotating relative to the connector housing. Also in some embodiments, the ultrasound transducer device includes an ultrasound transducer housing having a proximal end and a distal end. Again, the connector housing may be coupled, in some embodiments, with the distal end of the ultrasound transducer housing via coupling means allowing for manual coupling without using coupling tools. Such coupling may be by complementary threads on the two housings, pressure fitting or the like. In some embodiments, the ultrasound transducer housing further comprises at least one protrusion on its distal end and a slideable collar for fitting over the at least one protrusion to press a portion of the distal end of the ultrasound transducer housing against the connector housing, thereby further securing the ultrasound transducer housing to the connector housing.
In yet another aspect, an ultrasound catheter for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; a sonic connector coupled with the proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with an ultrasound transducer device; and means for coupling the sonic connector with the ultrasound transducer device while preventing the ultrasound transmission member from rotating relative to the catheter body. In some embodiments, the means for coupling comprises a housing for securing the sonic connector to prevent it from rotating relative to the housing.
In another aspect, an ultrasound catheter system for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; a sonic connector coupled with the proximal end of the ultrasound transmission member; a connector housing having a proximal end and a distal end, the distal end coupled with the proximal end of the catheter body, for housing the sonic connector and a proximal portion of the ultrasound transmission wire and for preventing the ultrasound transmission member from rotating relative to the catheter body; and an ultrasound transducer device removably couplable with the sonic connector and the proximal end of the connector housing.
In some embodiments, the ultrasound transducer device includes an ultrasound transducer housing comprising at least one protrusion on a distal end of the ultrasound transducer housing and a slideable collar for fitting over the at least one protrusion to press a portion of the distal end of the ultrasound transducer housing against the connector housing, thereby further securing the ultrasound transducer housing to the connector housing. In some embodiments, the at least one protrusion comprises a first ring member at least partially encircling a portion of the ultrasound transducer housing. Sometimes the first ring member may include at least one longitudinal slot which narrows when the slideable collar is fitted over the first ring member to reduce an inner diameter of the first ring member. In some embodiments, the collar comprises a second ring member with an inner diameter to fit over at least part of the first ring member. In many embodiments, the slideable collar is slideable between an uncoupled position in which it does not contact the at least one protrusion and a coupled position in which it fits over the at least one protrusion. In some of these embodiments, the slideable collar does not overlap the connector housing when the collar is disposed in the coupled position or the uncoupled position.
In yet another aspect, an ultrasound catheter for disrupting occlusions in blood vessels comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; and at least one anchor member for anchoring the distal head to at least a part of the ultrasound catheter. In some embodiments, the at least one anchor member is coupled with the distal head and the catheter body. In some embodiments, the at least one anchor member is coupled with the catheter body closer to the distal end of the body than the proximal end of the body. Alternatively, the at least one anchor member may be coupled with the catheter body closer to the proximal end of the body than the distal end of the body. In other embodiments, the at least one anchor member is coupled with the distal head and a guidewire tube, the guidewire tube disposed within the catheter body and coupled with the catheter body. In yet other embodiments, the at least one anchor member comprises a guidewire tube disposed within the catheter body and coupled with the catheter body. In some embodiments, the at least one anchor member is coupled with at least one of the distal head and the catheter body by means selected from the group consisting of bonding, welding, fusing, tying and heat shrinking. In some embodiments, the at least one anchor member comprises at least one of a metal and a polymer.
In another aspect, an ultrasound catheter for disrupting occlusions in blood vessels, comprises: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end, a distal end and a distal head, wherein the distal head and the rest of the ultrasound transmission member are manufactured from one piece of material; and a sonic connector coupled with the proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with an ultrasound transducer device. In some embodiments, the ultrasound transmission member comprises at least one material having superelastic properties. Also in some embodiments, the distal head of the ultrasound transmission member comprises at least one longitudinal aperture. For example, the at least one longitudinal aperture may comprise at least one of an irrigation aperture and a guidewire aperture. In some embodiments, the ultrasound transmission member tapers from a larger diameter at its proximal end to a smaller diameter adjacent the distal head.
In another aspect, an ultrasound catheter for disrupting occlusions in blood vessels, includes: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end, the ultrasound transmission member comprising a metal alloy including at least two metal components and having a tensile strength of between 170,000 Psi and 250,000 Psi; and a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, the distal head having an average density not to exceed 5 g/cm3. In some cases, the metal alloy comprises a superelastic alloy. For example, the superelastic alloy may be capable of elongation of between 7% and 17% in some embodiments. In one embodiment, the superelastic alloy comprises a nickel-titanium alloy having a nickel content of between 50.50 and 51.50 atomic weight. Optionally, the superelastic alloy may have a superelastic temperature range of between 10° C. and 50° C.
In still another aspect, an ultrasound catheter for disrupting occlusions in-blood vessels includes: an elongate flexible catheter body having a proximal end, a distal end and at least one lumen, the catheter body comprising at least in part a polymeric material having a flexural modulus of elasticity of less than 160 Psi; an ultrasound transmission member extending longitudinally through the lumen of the catheter body and having a proximal end and a distal end; a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body; and a sonic connector coupled with the proximal end of the ultrasound transmission member for coupling the ultrasound transmission member with an ultrasound transducer device. In some embodiments, the polymeric material comprises a polymeric block amide. In some embodiments, the polymeric block amide has a Shore D hardness value of between about 55 and about 75. Alternatively, the polymeric block amide may have a Shore D hardness value of between about 25 and about 55. Also in some embodiments, 5% or less of the polymeric material may comprise a colorant.
In another aspect of the invention, a method of manufacturing an ultrasound transmission member for use in an ultrasound catheter device involves: providing a generally cylindrically-shaped transmission member material; shaping the material to taper the transmission member from a first, wider end toward a second, narrower end; and forming a distal head at the second, narrower end. In some cases, providing the material comprises providing a polymer having superelastic properties. Shaping the material, in some embodiments, comprises grinding the material. Forming the distal head, in some embodiments, comprises forming a bullet-shaped head. Optionally, forming the distal head may further comprise forming at least one longitudinal aperture through the head to provide for passage of at least one of a guidewire and irrigation fluid.
In another aspect, a method for disrupting an occlusion in a blood vessel includes: positioning an ultrasound catheter in the blood vessel such that a distal end of the catheter is adjacent the occlusion; transmitting ultrasound energy to an ultrasound transmission member of the ultrasound catheter to disrupt the occlusion into multiple occlusion fragments; expanding an expandable balloon coupled with the ultrasound catheter at a location proximal to the distal end of the catheter; and removing at least some of the occlusion fragments from the blood vessel via the ultrasound catheter. In some embodiments, positioning the ultrasound catheter comprises guiding the catheter using a guidewire. Optionally, the occlusion fragments may be removed through at least one aperture in a catheter body of the ultrasound catheter. In some embodiments, for example, the at least one aperture is in fluid communication with at least one irrigation lumen and the occlusion fragments are removed through the at least one aperture and the at least one irrigation lumen. Alternatively, the at least one aperture may be in fluid communication with at least one guidewire lumen and the occlusion fragments are removed through the at least one aperture and the at least one guidewire lumen. In another embodiment, the occlusion fragments are removed through a sheath disposed around a portion of the ultrasound catheter. In any such embodiments, removing the occlusion fragments may comprise applying a vacuum force to guide the fragments into at least one aperture on the ultrasound catheter. For example, applying the vacuum may comprise using at least one of a syringe and a vacuum pump.
In another aspect of the invention, a method for disrupting an occlusion in a blood vessel comprises: introducing an ultrasound catheter into the blood vessel through a guide catheter; positioning the ultrasound catheter such that a distal end of the catheter is adjacent the occlusion; transmitting ultrasound energy to an ultrasound transmission member of the ultrasound catheter to disrupt the occlusion into multiple occlusion fragments; expanding an expandable balloon coupled with the guide catheter at a location proximal to the distal end of the catheter; and removing at least some of the occlusion fragments from the blood vessel via the ultrasound catheter. Optionally, introducing and positioning the ultrasound catheter may further comprise guiding the catheter using a guidewire.
In yet another aspect, a method for disrupting an occlusion in a blood vessel involves: positioning an ultrasound catheter in the blood vessel such that a distal end of the catheter is adjacent the occlusion; introducing at least one radiopaque fluid into the blood vessel through at least one aperture in the ultrasound catheter adjacent the distal end to enhance visualization of a location of the distal end; and transmitting ultrasound energy to an ultrasound transmission member of the ultrasound catheter to disrupt the occlusion into multiple occlusion fragments. Optionally, introducing the radiopaque fluid may comprise introducing through at least one irrigation aperture in the ultrasound catheter. Alternatively, introducing the radiopaque fluid may comprise introducing through at least one guidewire aperture in the ultrasound catheter. In yet other embodiments, introducing the radiopaque fluid comprises introducing through a sheath surrounding a portion of the ultrasound catheter and forming the at least one aperture.
Ultrasound catheter devices and methods of the present invention may generally be used for treating occlusions in blood vessels. Catheter devices generally include a catheter body, an ultrasound energy transmission member disposed within the catheter body and a distal head coupled with the energy transmission member and disposed at or near the distal end of the catheter body. The ultrasound transmission member transmits ultrasound energy from an ultrasound transducer to the distal head, causing the head to vibrate and, thus, disrupt vascular occlusions. A number of improved features of such ultrasound catheter devices are described more fully below.
Referring now to
In addition to proximal connector 12, ultrasound catheter device 10 may include one or more other various components, such as a Y-connector 11 or the like for providing access for irrigation, guidewire passage, suction or the like. Some embodiments of device include a rapid exchange guidewire 13, some include a proximal guidewire port 17 for over the wire guidewire deliver, and some embodiments include both. In some embodiments, Y-connector may include an irrigation port, for providing access for an irrigation tube 24. Irrigation tube 24, in some embodiments, may be used for introducing one or more fluids, applying vacuum, or both. Generally, catheter device 10 may include any suitable number of side-arms or ports for passage of a guidewire, infusing and/or withdrawing irrigation fluid, dye and/or the like, or any other suitable ports or connections. Also, ultrasound catheters 10 of the present invention may be used with any suitable proximal devices, such as any suitable ultrasound transducer 14, ultrasound generator 16, coupling device(s) and/or the like. Therefore, exemplary
Referring now to
In some embodiments, catheter body 22 is made from a polymeric material. Sometimes the polymer will have a desired amount of flexibility, such as in one embodiment where catheter body 22 is made of a polymer having a flexural modulus of less than about 160 Psi. In some embodiments, such a polymer will be one of any number of polyether block amides, although other polymers may of course be used. In some embodiments, such polyether block amides may have a Shore D hardness value ranging from about 55 to about 75, while in other embodiments they may have a Shore D hardness value ranging from about 25 to about 55. In some embodiments, the polymeric material includes up to about 5 weight percent of a colorant.
In most embodiments, ultrasound transmission member 24, wire, or wave guide extends longitudinally through catheter body lumen 21 to transmit ultrasonic energy from ultrasound transducer 14, connected to the proximal end of catheter 10, to the distal end of catheter 10. Ultrasound transmission member 24 may be formed of any material capable of effectively transmitting ultrasonic energy from ultrasound transducer 14 to the distal end of catheter body 22, including but not limited to metals such as pure titanium or aluminum, or titanium or aluminum alloys.
With continued reference to
In another embodiment, and with reference now to
Returning to
Distal segment 49 of bore 44 typically surrounds a portion of ultrasound transmission member 24 and may also contain one or more additional sets of absorber members 50. Distal segment 49 may also contain a portion of a Y-connector 11, which is coupled with the distal end of housing 42. Coupling of Y-connector 11 with the distal end of housing 42 may be accomplished via complementary threads, pressure fitting, or any other suitable means. A Y-connector lumen 48 of Y-connector 11 allows passage of ultrasound transmission member 24 and is in fluid communication with catheter body lumen 21.
Generally, pressurized fluid such as a coolant liquid may be infused through a side-arm 13 of Y-connector, through Y-connector lumen 48 and through catheter body lumen 21 so that it flows out of one or more fluid outflow apertures in distal head 26. The temperature and flow rate of such coolant liquid may be specifically controlled to maintain the temperature of ultrasound transmission member 24 at a desired temperature within its optimal working range. In particular, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a metal alloy which exhibits optimal physical properties (e.g. super elasticity) within a specific range of temperatures, the temperature and flow rate of coolant liquid infused through fluid infusion side-arm 13 may be specifically controlled to maintain the temperature of ultrasound transmission member 24 within a range of temperatures at which it demonstrates its most desirable physical properties. For example, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a shape memory alloy which exhibits super elasticity when in its martensite state, but which loses super elasticity as it transitions to an austenite state, it will be desirable to adjust the temperature and flow rate of the coolant liquid infused through fluid infusion side-arm 13 so as to maintain the shape memory alloy of ultrasound transmission member 24 within a temperature range at which the alloy will remain in its martensite state and will not transition to an austenite state. The temperature at which such shape memory alloys transition from a martensite state to an austenite state is known as the “martensite transition temperature” of the material. Thus, in these embodiments, the fluid infused through side-arm 13 will be at such temperature, and will be infused at such rate, as to maintain the shape memory alloy of ultrasound transmission member 24 below its martensite transition temperature.
Referring now to
With reference now to
Referring now to
With reference to
With reference now to
Generally, the various coupled components described above may be coupled by any suitable means, such as adhesives, complementary threaded members, pressure fittings, and the like. For example, distal head 26 may be coupled with ultrasound transmission member 24 and guidewire tube 28 with any suitable adhesive substance or via welding, bonding or the like. Adhesives used to attach guide wire tube 28, distal head 26 and/or catheter body 22 may include, but are not limited to cyanoacrylate (eg. Loctite™, Loctite Corp., Ontario, CANADA or Dron Alpha™, Borden, Inc., Columbus, Ohio) or polyurethane (e.g. Dymax™, Dymax Engineering Adhesive, Torrington, Conn.) adhesives. In some embodiments, guidewire tube 28 may also be coupled with catheter body 22 by adhesive, welding or other means. Some embodiments may also include one or more anchoring members for further securing distal head 26 to the ultrasound catheter device 10 and to help ensure that distal head 26 does not break free of catheter device 10.
For example, referring to
Finally, and with reference now to
In accordance with one aspect of the invention, all or a portion of ultrasound transmission member 24 may be formed of one or more materials 450 which exhibit superelastic properties. Such material(s) 450 should preferably exhibit superelasticity consistently within the range of temperatures normally encountered by ultrasound transmission member 24 during operation of ultrasound catheter apparatus 10. For example, in some embodiments, material 450 is an alloy having a tensile strength of between about 170,000 Psi and about 250,000 Psi. In some embodiments, the alloy exhibits elongation of between about 7% and about 17%. For example, in some embodiments the alloy is a nickel-titanium alloy having nickel content of between about 50.50 and about 51.50 atomic weight.
Use of superelastic metal alloys in ultrasound transmission members is described in U.S. Pat. No. 5,267,954, previously incorporated by reference. Examples of superelastic metal alloys which may be used are described in detail in U.S. Pat. No. 4,665,906 (Jervis); U.S. Pat. No. 4,565,589 (Harrison); U.S. Pat. No. 4,505,767 (Quin); and U.S. Pat. No. 4,337,090 (Harrison), the entire disclosures of which are hereby incorporated by reference insofar as they describe the compositions, properties, chemistries and behavior of specific metal alloys which are superelastic within the temperature range at which ultrasound transmission member 24 of the present invention operates, any and all of which superelastic metal alloys may be used to form ultrasound transmission member 24 of the present invention. In some embodiments, for example, the alloy exhibits a superelastic temperature range of about 10 degrees Celsius to about 50 degrees Celsius.
In many embodiments, ultrasound transmission member 24 includes a wider region 452 toward its proximal end and one or more tapered regions 454 towards its distal end. Tapered region 454 decreases the distal rigidity of ultrasound transmission member 24, thus amplifying ultrasound energy transmitted along ultrasound transmission member 24 to distal head 26. Distal head 26 may have any suitable configuration, shape, and size suitable for ablating or otherwise disrupting occlusions. For example, distal head 26 may have a shape that is bulbous, conical, cylindrical, circular, rectangular or the like. Similarly, distal head 26 may have dimensions which allow it to fit wholly or partially within the distal end of catheter body lumen 21 or may, alternatively, be disposed completely outside catheter body lumen 21. Thus, the configuration of distal head 26 may take any suitable form and should in no way be limited by the exemplary embodiments pictured in
In one embodiment, a method of making ultrasound transmission member 24 involves providing transmission member precursor material 450 (
Although the invention has been described above with specific reference to various embodiments and examples, it should be understood that various additions, modifications, deletions and alterations may be made to such embodiments without departing from the spirit or scope of the invention. Accordingly, it is intended that all reasonably foreseeable additions, deletions, alterations and modifications be included within the scope of the invention as defined in the following claims.
This application is a divisional of U.S. patent application Ser. No. 11/493,430, filed Jul. 25, 2006, entitled “METHOD OF MANUFACTURING AN ULTRASOUND TRANSMISSION MEMBER FOR USE IN AN ULTRASOUND CATHETER,” which issued as U.S. Pat. No. 8,062,566, on Nov. 22, 2011, which is a divisional of U.S. patent application Ser. No. 10/410,617, filed Apr. 8, 2003, entitled “ULTRASOUND CATHETER DEVICES AND METHODS,” which issued as U.S. Pat. No. 7,220,233 on May 22, 2007, both of which are incorporated herein by reference. This application is also related to the following U.S. patent applications, the full disclosures of which are all hereby incorporated by reference: U.S. patent application Ser. No. 10/229,371, filed Aug. 26, 2002, entitled “ULTRASOUND CATHETER FOR DISRUPTING BLOOD VESSEL OBSTRUCTIONS,” which issued as U.S. Pat. No. 7,137,963, on Nov. 21, 2006; U.S. patent application Ser. No. 10/345,078, filed Jan. 14, 2003, entitled “ULTRASOUND CATHETER AND METHODS FOR MAKING AND USING SAME,” which issued as U.S. Pat. No. 7,604,608, on Oct. 20, 2009; and U.S. patent application Ser. No. 10/375,903, filed Feb. 26, 2003, entitled “ULTRASOUND CATHETER APPARATUS,” which issued as U.S. Pat. No. 6,942,677 on Sep. 13, 2005.
Number | Name | Date | Kind |
---|---|---|---|
3433226 | Boyd | Mar 1969 | A |
3565062 | Kuris | Feb 1971 | A |
3612038 | Halligan et al. | Oct 1971 | A |
3631848 | Muller | Jan 1972 | A |
3719737 | Vaillancourt et al. | Mar 1973 | A |
3823717 | Pohlman et al. | Jul 1974 | A |
3839841 | Amplatz | Oct 1974 | A |
3896811 | Storz | Jul 1975 | A |
4016882 | Broadwin et al. | Apr 1977 | A |
4033331 | Guss et al. | Jul 1977 | A |
4136700 | Broadwin et al. | Jan 1979 | A |
4337090 | Harrison | Jun 1982 | A |
4368410 | Hance | Jan 1983 | A |
4417578 | Banko | Nov 1983 | A |
4425115 | Wuchinich | Jan 1984 | A |
4486680 | Bonnet et al. | Dec 1984 | A |
4505767 | Quin | Mar 1985 | A |
4545767 | Suzuki et al. | Oct 1985 | A |
4565589 | Harrison | Jan 1986 | A |
4565787 | Bossle et al. | Jan 1986 | A |
4572184 | Stohl et al. | Feb 1986 | A |
4664112 | Kensey et al. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4679558 | Kensey et al. | Jul 1987 | A |
4700705 | Kensey et al. | Oct 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4808153 | Parisi | Feb 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4854325 | Stevens | Aug 1989 | A |
4870953 | Donmicheal | Oct 1989 | A |
4886060 | Wiksell | Dec 1989 | A |
4920954 | Alliger | May 1990 | A |
4923462 | Stevens | May 1990 | A |
4924863 | Sterzer | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936845 | Stevens | Jun 1990 | A |
5000185 | Yock | Mar 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5046503 | Schneiderman | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5076276 | Sakurai | Dec 1991 | A |
5091205 | Fan | Feb 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5109859 | Jenkins | May 1992 | A |
5114414 | Buchbinder | May 1992 | A |
5116350 | Stevens | May 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5156143 | Bocquet et al. | Oct 1992 | A |
5163421 | Bernstein | Nov 1992 | A |
5171216 | Dasse et al. | Dec 1992 | A |
5180363 | Idemoto et al. | Jan 1993 | A |
5183470 | Wettermann | Feb 1993 | A |
5195955 | Don Michael | Mar 1993 | A |
5215614 | Wijkamp et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242385 | Strukel | Sep 1993 | A |
5243997 | Uflacker et al. | Sep 1993 | A |
5248296 | Alliger | Sep 1993 | A |
5255669 | Kubota et al. | Oct 1993 | A |
5267954 | Nita | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5269793 | Simpson | Dec 1993 | A |
5287858 | Hammerslag et al. | Feb 1994 | A |
5290229 | Paskar | Mar 1994 | A |
5304115 | Pflueger | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5312328 | Nita et al. | May 1994 | A |
5318014 | Carter | Jun 1994 | A |
5318570 | Hood et al. | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324260 | O'neill et al. | Jun 1994 | A |
5325860 | Seward et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5342292 | Nita et al. | Aug 1994 | A |
5344395 | Whalen et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5362309 | Carter | Nov 1994 | A |
5368557 | Nita | Nov 1994 | A |
5368558 | Nita | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5380274 | Nita | Jan 1995 | A |
5380316 | Aita et al. | Jan 1995 | A |
5382228 | Nita et al. | Jan 1995 | A |
5383460 | Jang et al. | Jan 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5391144 | Sakurai et al. | Feb 1995 | A |
5397293 | Alliger | Mar 1995 | A |
5397301 | Pflueger et al. | Mar 1995 | A |
5405318 | Nita | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5421923 | Clarke et al. | Jun 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431663 | Carter | Jul 1995 | A |
5443078 | Uflacker | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449369 | Imran | Sep 1995 | A |
5451209 | Ainsworth et al. | Sep 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5474531 | Carter | Dec 1995 | A |
5480379 | La Rosa | Jan 1996 | A |
5484398 | Stoddard | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5516043 | Manna et al. | May 1996 | A |
5527273 | Manna et al. | Jun 1996 | A |
5540656 | Pflueger et al. | Jul 1996 | A |
5542917 | Nita et al. | Aug 1996 | A |
5597497 | Dean et al. | Jan 1997 | A |
5597882 | Schiller et al. | Jan 1997 | A |
5607421 | Jeevanandam et al. | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5618266 | Liprie | Apr 1997 | A |
5626593 | Imran | May 1997 | A |
5649935 | Kremer et al. | Jul 1997 | A |
5658282 | Daw et al. | Aug 1997 | A |
5695460 | Siegel et al. | Dec 1997 | A |
5695507 | Auth et al. | Dec 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5728062 | Brisken | Mar 1998 | A |
5738100 | Yagami et al. | Apr 1998 | A |
5797876 | Spears et al. | Aug 1998 | A |
5816923 | Milo et al. | Oct 1998 | A |
5827203 | Nita | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5846218 | Brisken et al. | Dec 1998 | A |
5895397 | Jang et al. | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5904667 | Falwell | May 1999 | A |
5916192 | Nita et al. | Jun 1999 | A |
5916912 | Ames et al. | Jun 1999 | A |
5935142 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5937301 | Gardner et al. | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957899 | Spears et al. | Sep 1999 | A |
5964223 | Baran | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5971949 | Levin et al. | Oct 1999 | A |
5976119 | Spears et al. | Nov 1999 | A |
5989208 | Nita | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
6004280 | Buck et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6022309 | Celliers et al. | Feb 2000 | A |
6024764 | Schroeppel | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6030357 | Daoud et al. | Feb 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6113558 | Rosenschein et al. | Sep 2000 | A |
6123698 | Spears et al. | Sep 2000 | A |
6149596 | Bancroft | Nov 2000 | A |
6159176 | Broadwin et al. | Dec 2000 | A |
6165127 | Crowley | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6206842 | Tu et al. | Mar 2001 | B1 |
6210356 | Anderson et al. | Apr 2001 | B1 |
6217543 | Anis et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235007 | Divino, Jr. et al. | May 2001 | B1 |
6241692 | Tu et al. | Jun 2001 | B1 |
6241703 | Levin et al. | Jun 2001 | B1 |
6277084 | Abele et al. | Aug 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287271 | Dubrul et al. | Sep 2001 | B1 |
6287285 | Michal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6296620 | Gesswein et al. | Oct 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6309358 | Okubo | Oct 2001 | B1 |
6315741 | Martin et al. | Nov 2001 | B1 |
6379378 | Werneth et al. | Apr 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6398736 | Seward | Jun 2002 | B1 |
6416533 | Gobin et al. | Jul 2002 | B1 |
6423026 | Gesswein et al. | Jul 2002 | B1 |
6433464 | Jones | Aug 2002 | B2 |
6434418 | Neal et al. | Aug 2002 | B1 |
6450975 | Brennan et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6484052 | Visuri et al. | Nov 2002 | B1 |
6491707 | Makower | Dec 2002 | B2 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6508781 | Brennan et al. | Jan 2003 | B1 |
6508784 | Shu | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6547754 | Evans et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6554846 | Hamilton et al. | Apr 2003 | B2 |
6558502 | Divino, Jr. et al. | May 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6573470 | Brown et al. | Jun 2003 | B1 |
6589253 | Cornish et al. | Jul 2003 | B1 |
6596235 | Divino, Jr. et al. | Jul 2003 | B2 |
6615062 | Ryan et al. | Sep 2003 | B2 |
6616617 | Ferrera et al. | Sep 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6635017 | Moehring et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6660013 | Rabiner | Dec 2003 | B2 |
6676900 | Divino, Jr. et al. | Jan 2004 | B1 |
6682502 | Bond et al. | Jan 2004 | B2 |
6685657 | Jones | Feb 2004 | B2 |
6689086 | Nita et al. | Feb 2004 | B1 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Ranucci et al. | Feb 2004 | B2 |
6695810 | Peacock, III et al. | Feb 2004 | B2 |
6702748 | Nita et al. | Mar 2004 | B1 |
6702750 | Yock | Mar 2004 | B2 |
6719725 | Milo et al. | Apr 2004 | B2 |
6729334 | Baran | May 2004 | B1 |
6733451 | Rabiner et al. | May 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6866670 | Rabiner et al. | Mar 2005 | B2 |
6936025 | Evans et al. | Aug 2005 | B1 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942620 | Nita et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7131983 | Murakami | Nov 2006 | B2 |
7137963 | Nita et al. | Nov 2006 | B2 |
7150853 | Lee et al. | Dec 2006 | B2 |
7166098 | Steward et al. | Jan 2007 | B1 |
7267650 | Chow et al. | Sep 2007 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7384407 | Rodriguez et al. | Jun 2008 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7540852 | Nita et al. | Jun 2009 | B2 |
7604608 | Nita et al. | Oct 2009 | B2 |
7621929 | Nita et al. | Nov 2009 | B2 |
7776025 | Bobo, Jr. | Aug 2010 | B2 |
7938819 | Kugler et al. | May 2011 | B2 |
8083727 | Kugler et al. | Dec 2011 | B2 |
8226566 | Nita | Jul 2012 | B2 |
20020077643 | Rabiner et al. | Jun 2002 | A1 |
20030009153 | Brisken et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030125620 | Satou et al. | Jul 2003 | A1 |
20030199817 | Thompson et al. | Oct 2003 | A1 |
20030216732 | Truckai et al. | Nov 2003 | A1 |
20030225332 | Okada et al. | Dec 2003 | A1 |
20040138570 | Nita et al. | Jul 2004 | A1 |
20040167507 | Nita et al. | Aug 2004 | A1 |
20040204670 | Nita et al. | Oct 2004 | A1 |
20050113688 | Nita et al. | May 2005 | A1 |
20050215946 | Hansmann et al. | Sep 2005 | A1 |
20050222557 | Baxter et al. | Oct 2005 | A1 |
20070037119 | Pal et al. | Feb 2007 | A1 |
20070260172 | Nita | Nov 2007 | A1 |
20080108937 | Nita | May 2008 | A1 |
20080228111 | Nita | Sep 2008 | A1 |
20080287804 | Nita | Nov 2008 | A1 |
20110130834 | Wilson et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
2256127 | May 1974 | DE |
2438648 | Feb 1976 | DE |
3821836 | Jan 1990 | DE |
8910040 | Jan 1990 | DE |
4042435 | Aug 1991 | DE |
0005719 | Dec 1979 | EP |
0316789 | May 1989 | EP |
0376562 | Jul 1990 | EP |
0379156 | Jul 1990 | EP |
0394583 | Oct 1990 | EP |
0443256 | Aug 1991 | EP |
0541249 | May 1993 | EP |
0820728 | Jan 1998 | EP |
1323481 | Jul 2003 | EP |
1106957 | Mar 1968 | GB |
SHO61-272045 | Dec 1986 | JP |
01099547 | Apr 1989 | JP |
2-71510 | May 1990 | JP |
U03067608 | Jul 1991 | JP |
2006086822 | Mar 1994 | JP |
2007116260 | May 1995 | JP |
10216140 | Aug 1998 | JP |
2001104356 | Apr 2001 | JP |
2001321388 | Nov 2001 | JP |
2002186627 | Jul 2002 | JP |
2005-253874 | Sep 2005 | JP |
WO8705739 | Sep 1987 | WO |
WO8906515 | Jul 1989 | WO |
WO9001300 | Feb 1990 | WO |
WO9004362 | May 1990 | WO |
WO9107917 | Jun 1991 | WO |
WO9211815 | Jul 1992 | WO |
WO9308750 | May 1993 | WO |
WO9316646 | Sep 1993 | WO |
WO9412140 | Jun 1994 | WO |
WO9414382 | Jul 1994 | WO |
WO9508954 | Apr 1995 | WO |
WO9509571 | Apr 1995 | WO |
WO 9515192 | Jun 1995 | WO |
WO9635469 | Nov 1996 | WO |
WO9705739 | Feb 1997 | WO |
WO 9721462 | Jun 1997 | WO |
WO9745078 | Dec 1997 | WO |
WO9827874 | Jul 1998 | WO |
WO9852637 | Nov 1998 | WO |
WO9925412 | May 1999 | WO |
WO0053341 | Sep 2000 | WO |
WO0067830 | Nov 2000 | WO |
WO2004012609 | Feb 2004 | WO |
WO2004112888 | Dec 2004 | WO |
WO 2006049593 | May 2006 | WO |
Entry |
---|
Health Care Without Harm [report], Non-Incineration Medical Waste Treatment Technologies, “Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems”, Chapter 9., Aug. 2001, pp. 69-74. |
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351. |
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4. |
Chandra Sehgal et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943. |
http://www.merriam-webster.com/dictionary/couple, definition of the term coupled retrieved on, May 18, 2013. |
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by ‘therapeutic’ ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676. |
Number | Date | Country | |
---|---|---|---|
20120016272 A1 | Jan 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11493430 | Jul 2006 | US |
Child | 13243648 | US | |
Parent | 10410617 | Apr 2003 | US |
Child | 11493430 | US |